CYP3A4 and chronic kidney disease: A previous study had demonstrated a positive correlation between serum IS concentrations and the need for higher doses of cyclosporine, a drug metabolized by CYP3A, to attain target blood concentrations in transplant recipients and individuals with chronic kidney disease [34].